Thyrocare Technologies Limited — Regulatory Filings 2020

Jun 30, 2020

Think Thyroid. Think Thyrocare.

==> picture [43 x 356] intentionally omitted <==

==> picture [37 x 455] intentionally omitted <==

ocare[®] Thyr

June 30, 2020

The Secretary, Listing Department, National Stock Exchange of India Limited Exchange Plaza, 5[th ] Floor, C/1 G Block, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051

The Secretary, Listing Department, BSE Limited Phiroze Jeejeeboy Towers Dalal Street, Mumbai- 400 001

(Scrip Code: 539871)

(Scrip Code: THYROCARE)

Dear Sir/Madam,

Sub: Intimation of closure of trading window under the provisions of SEBI (rohibition of Insider Trading) Regulations, 2015.

This is to inform you that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, as amended, and in accordance with the Company's Code relating to prohibition of insider trading, the trading window of the Company will remain closed for trading in Company's · equity shares for Directors/ Designated Employees/ Connected Persons covered by the said Code, with effect from July O 1, 2020, and would be re-opened after 48 hours of date of announcement/ declaration of Unaudited Financial Results for the Quarter ended June 30, 2020.

We request you to please take the same on record.

Yours Faithfully,

For Thyrocare Technologies Limited,

==> picture [78 x 39] intentionally omitted <==

Ramjee Dorai

Company Secretary and Compliance Officer

· · -

Thyrocare Technologies Limited

• 9 D-37/1, TTC MIDC, Turbhe, Navi Mumbai 400 703, India (9 022- 3090 0000 / 4125 2525 to'l".i enquiry@thyrocare.com (@ www.thyrocare.com

(CIN L85110MH2000PLC123882)